Shorter durations and lower doses of peginterferon alfa‐2a are associated with inferior hepatitis B e antigen seroconversion rates in hepatitis B virus genotypes B or C
Liaw, Y.‐F., Jia, J.‐D., Chan, H.L.Y., Han, K.H., Tanwandee, T., Chuang, W.L., Tan, D.M., Chen, X.Y., Gane, E., Piratvisuth, T., Chen, L., Xie, Q., Sung, J.J.Y., Wat, C., Bernaards, C., Cui, Y., Marcellin, P.
Published in Hepatology (Baltimore, Md.) (01.11.2011)
Published in Hepatology (Baltimore, Md.) (01.11.2011)
Get full text
Journal Article
Randomized clinical trial: efficacy and safety of telbivudine and lamivudine in treatment-naïve patients with HBV-related decompensated cirrhosis
Chan, H. L.Y., Chen, Y. C., Gane, E. J., Sarin, S. K., Suh, D. J., Piratvisuth, T., Prabhakar, B., Hwang, S. G., Choudhuri, G., Safadi, R., Tanwandee, T., Chutaputti, A., Yurdaydin, C., Bao, W., Avila, C., Trylesinski, A.
Published in Journal of viral hepatitis (01.10.2012)
Published in Journal of viral hepatitis (01.10.2012)
Get full text
Journal Article
Multicenter Evaluation of the Elecsys Hepatitis B Surface Antigen Quantitative Assay
Zacher, B J, Moriconi, F, Bowden, S, Hammond, R, Louisirirotchanakul, S, Phisalprapa, P, Tanwandee, T, Wursthorn, K, Brunetto, M R, Wedemeyer, H, Bonino, F
Published in Clinical and Vaccine Immunology (01.11.2011)
Published in Clinical and Vaccine Immunology (01.11.2011)
Get full text
Journal Article
Responses are durable for up to 5 years after completion of peginterferon alfa‐2a treatment in hepatitis B e antigen‐positive patients
Chuang, W.‐L., Jia, J., Chan, H. L. Y., Han, K.‐H., Tanwandee, T., Tan, D., Chen, X., Gane, E., Piratvisuth, T., Chen, L., Xie, Q., Sung, J. J.‐Y., Messinger, D., Wat, C., Bakalos, G., Liaw, Y. F.
Published in Alimentary pharmacology & therapeutics (01.05.2018)
Published in Alimentary pharmacology & therapeutics (01.05.2018)
Get full text
Journal Article
Pharmacokinetics, safety and antiviral activity of CMX157, a novel prodrug of tenofovir, administered as ascending multiple doses to healthy volunteers and Hepatitis B virus-infected subjects
Tanwandee, T, Chatsiricharoenkul, S, Thongsawat, S, Sukeepaisarnjaroen, W, Tangkijvanich, P, Komolmit, P, Avihingsanon, A, Piratvisuth, T, Sunthi, P, Mahasanprasert, T, Matkovits, T, Conover, M, Cobb, J, Canizares, C, Sullivan-Bolyai, J
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
P407 HBeAg INDEX AND HBVDNA REDUCTION CAN PREDICT LONG TERM RESPONSE OF CHRONIC HEPATITIS B, HBeAg POSITIVE PATIENTS TREATED WITH PEGINTERFERON ALPHA-2a: A THREE-YEAR FOLLOW-UP
Phisalprapa, P, Charatcharoenwitthaya, P, Chainuwatti, S, Chotiyaputta, W, Nimanong, S, Tanwandee, T
Published in Journal of hepatology (01.04.2014)
Published in Journal of hepatology (01.04.2014)
Get full text
Journal Article
Efficacy and safety of elbasvir/grazoprevir in treatment-naïve patients with chronic HCV GT 1, GT 4 and GT 6 infection (C-CORAL): a phase III randomized multinational clinical trial
Wei, L, Zhdanov, K, Burnevich, E, Sheen, I.-S, Heo, J, Nguyen, V.K, Tanwandee, T, Cheng, P.-N, Kim, D.Y, Tak, W.Y, Kizhlo, S, Zhongping, D, Peng, C.-Y, Liang, L.W, Evans, B, Hanna, G, Barr, E, Robertson, M, Ingravallo, P, Talwani, R, George, J
Published in Journal of hepatology (2017)
Published in Journal of hepatology (2017)
Get full text
Journal Article
HBeAg Seroconversion Rates after Five Years of Follow-Up in Patients Treated with Peginterferon Alfa-2a (40kd) in Neptune: Final Results of the Son of Neptune Long-Term Follow-Up Study
Chuang, W.-L, Jia, J, Chan, H.L.-Y, Han, K.-H, Tanwandee, T, Tan, D, Chen, X, Gane, E, Piratvisuth, T, Chen, L, Xie, Q, Sung, J.J.-Y, Messinger, D, Wat, C, Bakalos, G, Liaw, Y.-F
Published in Journal of hepatology (2016)
Published in Journal of hepatology (2016)
Get full text
Journal Article
1208 BIT225, AN HCV-P7 INHIBITOR, WITH ENHANCED ANTI-HCV ACTIVITY IN COMBINATION WITH PEGYLATED INTERFERONalfa- 2b AND RIBAVIRIN IN HCV GENOTYPE-1 TREATMENT NAÏVE SUBJECTS: PHARMACOKINETIC AND RESISTANCE STUDIES
Ewart, G, Luscombe, C, Huang, Z, Miller, M, Wilkinson, J, Murphy, R, Tanwandee, T
Published in Journal of hepatology (01.04.2013)
Published in Journal of hepatology (01.04.2013)
Get full text
Journal Article
Adding Boceprevir Yields Better Cost-Saving for Chronic Hepatitis C Genotype 1 Treatment in Thailand
Ferrante, S, Elbasha, E.H, Piratvisuth, T, Tanwandee, T, Lerdlitruangsin, S, Thongsawat, S
Published in Value in health (01.11.2014)
Published in Value in health (01.11.2014)
Get full text
Journal Article
P0612 : Interferon-gamma-inducible protein 10 promoter polymorphism related with end-of-treatment HBsAg levels and had complementary role in prediction of sustained virologic response to peginterferon in HBeAg-negative chronic hepatitis B: Multicenter study
Thanapirom, K, Suksawatamnuay, S, Sukeepaisarnjareon, W, Tanwandee, T, Thongsawat, S, Leerapun, A, Piratvisuth, T, Boonsirichan, R, Bunchorntavakul, C, Pattanasirigool, C, Pornthisarn, B, Tantipanichtheerakul, S, Sripariwuth, E, Jeamsripong, W, Sanpajit, T, Poovorawan, Y, Komolmit, P
Published in Journal of hepatology (01.04.2015)
Published in Journal of hepatology (01.04.2015)
Get full text
Journal Article
1142 INCREASED BONE MINERAL DENSITY IN CHRONIC HEPATITIS C PATIENTS AFTER TREATMENT WITH PEGYLATED INTERFERON/RIBAVIRIN COMBINATION
Bunchorntavakul, C, Chotiyaputta, W, Nimanong, S, Chainuvati, S, Charatcharoenwitthaya, P, Sriussadaporn, S, Tanwandee, T
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
Foster, G. R., Zeuzem, S., Pianko, S., Sarin, S. K., Piratvisuth, T., Shah, S., Andreone, P., Sood, A., Chuang, W.-L., Lee, C.-M., George, J., Gould, M., Flisiak, R., Jacobson, I. M., Komolmit, P., Thongsawat, S., Tanwandee, T., Rasenack, J., Sola, R., Messina, I., Yin, Y., Cammarata, S., Feutren, G., Brown, K. K.
Published in Journal of viral hepatitis (01.04.2013)
Published in Journal of viral hepatitis (01.04.2013)
Get full text
Journal Article
539 2-YEAR RESULTS OF TELBIVUDINE (LDT) ROADMAP STUDY VERIFY THE OPTIMAL EFFICACY AND SAFETY RESULTS IN HBEAG POSITIVE CHRONIC HEPATITIS B (CHB) PATIENTS
Piratvisuth, T, Komolmit, P, Tanwandee, T, Sukeepaisarnjaroen, W, Chan, H.L, Pessoa, M.G, Fassio, E, Ono-Nita, S, Bessone, F, Daruich, J, Zeuzem, S, Cheinquer, H, Dong, Y, Trylesinski, A
Published in Journal of hepatology (01.04.2012)
Published in Journal of hepatology (01.04.2012)
Get full text
Journal Article
738 HIGHEST RATES OF RESPONSE AT WEEK 72 OF THE NEPTUNE STUDY ARE ACHIEVED WITH PEGINTERFERON ALFA-2A 180 μG FOR 48 WEEKS
Marcellin, P, Xie, Q, Sung, J, Tanwandee, T, Han, K, Wat, C, Hsu, C.-W, Jia, J
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3
Pianko, S., Zeuzem, S., Chuang, W.-L., Foster, G. R., Sarin, S. K., Flisiak, R., Lee, C.-M., Andreone, P., Piratvisuth, T., Shah, S., Sood, A., George, J., Gould, M., Komolmit, P., Thongsawat, S., Tanwandee, T., Rasenack, J., Li, Y., Pang, M., Yin, Y., Feutren, G., Jacobson, I. M.
Published in Journal of viral hepatitis (01.09.2012)
Published in Journal of viral hepatitis (01.09.2012)
Get full text
Journal Article
424 RESPIRATORY ALTERATIONS IN GENOTYPE 2/3 CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON OR ALBINTERFERON-ALFA-2B PLUS RIBAVIRIN IN A RANDOMIZED STUDY
Foster, G, Flisiak, R, Chuang, W.-L, George, J, Rasenack, J, Sood, A, Komolmit, P, Thongsawat, S, Tanwandee, T, Sola, R, Sukeepaisarnjaroen, W, Weltman, M, Yin, Y, Feutren, G, Brown, K
Published in Journal of hepatology (01.03.2011)
Published in Journal of hepatology (01.03.2011)
Get full text
Journal Article
7 TREATMENT OF DECOMPENSATED HBV-CIRRHOSIS: RESULTS FROM 2-YEARS RANDOMIZED TRIAL WITH TELBIVUDINE OR LAMIVUDINE
Gane, E.J, Chan, H.L, Choudhuri, G, Suh, D.J, Chutaputti, A, Safadi, R, Tanwandee, T, Thongsawat, S, Assy, N, Sarin, S.K, Bao, W, Trylesinski, A, Avila, C
Published in Journal of hepatology (2010)
Published in Journal of hepatology (2010)
Get full text
Journal Article
180 ORAL L-ORNITHINE-L-ASPARTATE (LOLA) FOR PATIENTS WITH OVERT HEPATIC ENCEPHALOPATHY TREATED WITH LACTULOSE; A RANDOMIZED, DOUBLE-BLINDED, PLACEBO-CONTROLLED TRIAL
Nimanong, S, Siwaporn, C, Sansak, I, Tanwandee, T, Charatcharoenwitthaya, P, Chotiyaputta, W, Boonyapisit, K, Pausawasdi, N, Prachayakul, W, Pongprasobchai, S, Leelakusolvong, S, Manatsathit, S, Kachintorn, U
Published in Journal of hepatology (2010)
Published in Journal of hepatology (2010)
Get full text
Journal Article